FUJIFILM Holdings Co. (OTCMKTS:FUJIY - Get Free Report) saw a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 219,100 shares, a growth of 1,652.8% from the May 15th total of 12,500 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 240,900 shares, the short-interest ratio is currently 0.9 days.
FUJIFILM Trading Up 0.3%
FUJIY traded up $0.03 during trading on Friday, reaching $11.03. The company had a trading volume of 107,977 shares, compared to its average volume of 222,867. The company has a quick ratio of 0.92, a current ratio of 1.45 and a debt-to-equity ratio of 0.14. The business has a 50 day simple moving average of $10.53 and a 200-day simple moving average of $10.46. The stock has a market cap of $27.44 billion, a P/E ratio of 9.85, a PEG ratio of 2.07 and a beta of 0.70. FUJIFILM has a 52 week low of $8.69 and a 52 week high of $13.88.
FUJIFILM (OTCMKTS:FUJIY - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The technology company reported $0.22 EPS for the quarter, topping analysts' consensus estimates of $0.18 by $0.04. The firm had revenue of $6.06 billion during the quarter, compared to analysts' expectations of $822.51 billion. FUJIFILM had a net margin of 8.02% and a return on equity of 7.62%. On average, equities analysts anticipate that FUJIFILM will post 0.66 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen cut FUJIFILM from a "buy" rating to a "hold" rating in a research note on Friday, May 23rd.
Read Our Latest Stock Report on FUJIFILM
About FUJIFILM
(
Get Free Report)
FUJIFILM Holdings Corporation develops, manufactures, sells, and services imaging, healthcare, materials, and business innovation solutions worldwide. The company's Healthcare segment provides products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment.
See Also
Before you consider FUJIFILM, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and FUJIFILM wasn't on the list.
While FUJIFILM currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
